Metastatic renal cell carcinoma: recent advances in the targeted therapy era.

Source:
European Association of Urology - EAU
Publisher:
European Association of Urology (EAU)
Publication date:
07 September 2009

Abstract

 

An analytical view on the medical management of metastatic renal cell carcinoma (mRCC) which has recently evolved from being predominantly cytokine based to being grounded in the use of targeted agents.  A treatment algorithm based on the best available evidence is therefore postulated.